A Phase 3 interventional study of 0.412% stannous fluoride toothpaste and flat trimmed toothbrush and 0.76% Na MFP and flat trimmed toothbrush in Plaque and Gingivitis, sponsored by Colgate Palmolive. Completed at 1 site in Dominican Republic. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 44 studies in Gingivitis by Colgate Palmolive — 8 open to participants now, 9 under way, 5 of them phase 3. Gingivitis · Colgate Palmolive.
Among the 44 studies in Gingivitis by Colgate Palmolive, this one is the 31st largest by enrollment, is one of 12 that started in 2026, is one of 25 in phase 3, and was the 44th registered.
631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.
Browse Gingivitis studies →8 of the 44 studies in Gingivitis by Colgate Palmolive are open now, in 5 countries. Recruiting first, the newest first:
Colgate Palmolive · Sites in Italy
Ages 18–70 · Healthy volunteers
Colgate Palmolive · Sites in United States
Ages 18+
Colgate Palmolive · Sites in Germany
Ages 18–70 · Healthy volunteers
Colgate Palmolive · Sites in China
Ages 18–70 · Healthy volunteers
Colgate Palmolive
Ages 60+ · Healthy volunteers
By country, each count listing its studies:
Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
44 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 84 is above the median of 66 across 507 interventional studies indexed under Gingivitis.
Median enrollment 94 across the 44 interventional studies. Of the 35 that completed or were terminated, 8 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
5 of the studies in Gingivitis by Colgate Palmolive that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07605338Phase 3Colgate PalmoliveTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. | 2026-11 |
| NCT07842991Phase 3Colgate PalmoliveClinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems | 2027-01 |
| NCT07842978Phase 3Colgate PalmoliveClinical Study Examining the Control of Plaque and Gingivitis | 2027-04 |
| NCT06966492Colgate PalmoliveInvestigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses. | 2027-06 |
| NCT07807397Colgate PalmoliveOral Hygiene Assistance Training Program | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 44 studies in Gingivitis by Colgate Palmolive, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Clinical Research study to assess the efficacy of two brushing regimens: 1) a toothpaste containing stannous fluoride and a standard manual toothbrush as compared to 2) a regular fluoride toothpaste and standard manual toothbrush in the reduction of established dental plaque and gingivitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Brush with a full ribbon, 2x day / 2mins
Drug: 0.412% stannous fluoride toothpaste and flat trimmed toothbrush
Brush with a full ribbon, 2x day / 2mins
Drug: 0.76% Na MFP and flat trimmed toothbrush
Brush with full ribbon, 2x day / 2mins
Brush with full ribbon, 2x day / 2mins
Loe-Silness Gingival Index
score from 0 to 3 will be assigned by the examining dentist to all scorable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scorable surface and dividing that number by the total number of surfaces scored
Time frame: Baseline, 12 weeks (3 months), 24 weeks (6 months)
Turesky-modified Quigley-Hein Plaque Index
Using a red dye solution to disclose the plaque. A score of 0 to 5 will be assigned to all scoreable disclosed surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth score for each subject will be determined by adding the values given by the dental examiner to each scoreable surface and dividing that number by the total number of surfaces scored
Time frame: Baseline, 12 weeks (3 months), 24 weeks (6 months)
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2026 to primary completion in Nov 2026, 0 months.
Of 23 industry-sponsored phase 3 interventional studies under Gingivitis, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 0 months is below that.
Counting every sponsor, half of 35 studies reached it within 3 months; a quarter within 2 and three quarters within 6.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Apr 2027 → Nov 2026 and completion Apr 2027 → Nov 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.